Pharmaceutical and life sciences companies must consider a wide range of emerging risks as they adapt their business practices to changing regulatory compliance and market-driven pressures. Some of these include globalization, the advancement of technology and expanding stakeholder expectations. Risks are no longer confined to discrete areas and functions within organizations. From regulatory pressures to consumer demands for increased transparency, organizations are increasingly seeking total solutions. New information systems, strategies, and processes to manage compliance are rapidly evolving in response to these pressures.
A pharmaceutical or life science company’s risk management program may not be keeping pace with its appetite for growth. Going beyond traditional strategies, PwC identifies ways in which risk management can actually improve your company’s bottom line.
How do we create comprehensive compliance plans that address governance and operations challenges? PwC performs thorough risk analyses; designs strategic plans that align business, medical and patient needs; and facilitates program implementation so that clients can achieve critical objectives. We also...
Our team is anchored by experts in technology, finance, regulations, cybersecurity and privacy, business processes and data analytics. We provide insight, advisory services and independent assurance that enable pharmaceutical and life sciences organizations like yours make informed decisions and create invaluable safeguards in a complex risk environment.
Read more about our approach to transforming risk to your advantage.
Principal, Pharmaceutical and Life Sciences Risk and Regulatory Leader, PwC US
US Pharmaceutical and Life Sciences Risk Assurance Leader, PwC US
Partner, Pharmaceutical & Life Sciences Transparency Leader, PwC US